Key Dates

Related Announcements

• April 29, 2024 - Notice to change the expiration date of PAR-21-255: Investigator Initiated Research in Computational genomics and Data Science (R21 Clinical Trial Not Allowed). See Notice NOT-HG-24-034.
• July 30, 2021 - Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed). See NOFO PAR-21-254.
• July 30, 2021 - Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed). See NOFO PAR-21-255.

Issued by

National Human Genome Research Institute (NHGRI)

Purpose

The purpose of this notice is to extend the expiration date for PAR-21-254: Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) by one review cycle.

An additional receipt date has been added: October 5, 2024 for new applications and November 5, 2024 for resubmission and revision applications. This Notice of Funding Opportunity now expires on January 8, 2025. The changes below are in bold italics.

The Notice of Funding Opportunity currently reads as:

Part 1. Overview Information, Key Dates

Application Due Date(s): Standard dates apply. The first standard due date for this FOA is Oct 5,2021.

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review: Standard dates apply

Advisory Council Review: Standard dates apply

Earliest Start Date: Standard dates apply

Expiration Date: September 8, 2024
 

The Notice of Funding Opportunity has been modified as follows:

Part 1. Overview Information, Key Dates

Application Due Date(s): Standard dates apply. The first standard due date for this FOA is Oct 5,2021.

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review: Standard dates apply

Advisory Council Review: Standard dates apply

Earliest Start Date: Standard dates apply

Expiration Date: January 8, 2025
 

All other aspects of this NOFO remain the same.

Inquiries

Please direct all inquiries to:

Daniel Gilchrist, Ph.D.
National Human Genome Research Institute (NHGRI)
Email: [email protected]